4th Advances in Heart Failure 2021
4th Advances in
Heart Failure 2021
O foco central será a divulgação, em primeira mão, dos desenvolvimentos científicos mais recentes nesta área apresentados no Congresso Europeu de Cardiologia, nomeadamente as novas Recomendações da Sociedade Europeia de Cardiologia para a Insuficiência Cardíaca.
Este encontro científico ganha o seu pleno significado pela participação de um extenso corpo docente, constituído pelos peritos mais relevantes na área da Insuficiência Cardíaca, provenientes de todos os pontos do país e coadjuvado por peritos internacionais da mais elevada craveira.
Estamos certos que a troca de informação e a discussão de ideias neste momento de mudança assinalável da abordagem da Insuficiência Cardíaca contribuirá, em última instância, para uma melhoria significativa dos cuidados a prestar aos doentes com Insuficiência Cardíaca no nosso país.
Reunião em formato virtual
José Silva Cardoso
Elisabete Martins
Emília Moreira
PROGRAMA
17th September 2021
- Manhã | 10:15 – 12:30
Morning – Heart Failure with Preserved Ejection Fraction
| 10:15 | Opening session  Chairpersons: José Silva-Cardoso; Elisabete Martins Welcome: Francisco Cruz |
| 10:30 | Heart Failure: Towards a universal definition Chair: Nuno Cardim Speaker: Elisabete Martins Panel: Ana Oliveira Soares; Pedro Morais Sarmento |
| 11:00 | Heart Failure epidemiology in Portugal 2021 – The PORTHOS study methodology Co-Chairs: Victor Gil; Lino Gonçalves Speaker: Cristina Gavina e Rui Baptista Panel: José Silva-Cardoso; Cândida Fonseca |
| 11:30 | Artificial intelligence analysis for heart failure diagnosis and management Chair: João Gama – AI in heart failure: Expectations, challenges and methods Pedro Rodrigues – AI in heart failure diagnosis Miguel Coimbra – New solutions and data quality in the clinical practice Ricardo Correia Panel: Sofia Cabral; Ana Teresa Timóteo |
| 12:00 | Covid-19 and heart failure: Two years after Chair: Jorge Gonçalves Speakers: Roberto Roncon Panel: Mónica Pedro; Inês Araújo |
| 12:30 | Industry Session Servier Sacubitril/valsartan in the first-line of HFrEF treatment in 2021: Implications for patients Chair: José Silva-Cardoso Speaker: Carlos Aguiar Discussion: José Silva-Cardoso; Carlos Aguiar |
- Tarde | 14:00 – 20:00
Afternoon – Heart Failure with Preserved Ejection Fraction
| 14:00 | HFrEF therapy: Main principles Chair: Filipe Macedo Speaker: Dulce Brito – Time is of essence – Combination of drugs’ effects – Initiate first, titrate later Panel: Inês Almeida; Luís Oliveira |
| 14:30 | HFrEF therapy: Patient profiling Chair: Carlos Aguiar Speaker: Brenda Moura Panel: Susana Costa; Nuno Lousada |
| 15:00 | HFrEF therapy ESC algorithm: The nucleus Chair: Luís Menezes Falcão Speaker: Faiez Zannad Panel: Marisa Peres; Manuel Campelo |
| 15:30 | Industry Session Novartis Wind of Change Discussion: José Silva-Cardoso; Dulce Brito |
| 16:00 | ESC/ McMurray-Packer / ACC / CCS-CHFS heart failure treatment algorithms: A comparison Chair: Dulce Brito Speaker: Cândida Fonseca Panel: Fátima Franco; José Silva-Cardoso |
| 16:30 | Simpósio Astrazeneca The foundational role of Dapagliflozin in 2021’s HF management President: José Silva-Cardoso SGLT2i are a 1st line therapy in HFrEF. What was the contribution of DAPA-HF? Speaker: Rui Baptista Does SGLT2i fit with every HFrEF patient? Speaker: Brenda Moura |
| 17:00 | The Portuguese Experts’ HFrEF treatment consensus: The algorithm Chair: Aurora Andrade Speaker: José Silva-Cardoso Panel: Cândida Fonseca; João Morais |
| 17:30 | The Portuguese Experts’ HFrEF consensus: The safety and monitoring protocol Chair: Marisa Peres Speaker: Dulce Brito Panel: Fátima Franco; Jorge Ferreira |
| 18:00 | Telemedicine and other strategies for expeditious HFrEF therapy initiation Chair: José Ramón Juanatey Speaker: Josep Comin Colet Panel: João Agostinho; Manuel Campelo |
| 18:30 | The GUIDE-HF study results: Invasive telemonitoring for the management of heart failure Chair: Sérgio Baptista Speaker: Tiago Pereira da Silva Panel: Roberto Pinto; Daniel Caeiro |
| 19:00 | Remote management of Heart Failure: where do we stand after the GUIDE-HF study and the 2021 ESC HF-Guidelines Chair: José Silva-Cardoso Speaker: Friedrich Koehler Panel: Emília Moreira; Elisabete Martins |
| 19:30 | Patient empowerment and education to improve treatment adherence Chair: José Ilídio Moreira Speaker: Emília Moreira Panel: Sara Gonçalves; Ana Camacho |
| 20:00 | Closure Chairpersons: José Silva-Cardoso; Elisabete Martins |
18th September 2021
- Manhã | 09:00 – 13:00
Morning – Heart Failure with preserved Ejection Fraction
| 09:30 | HFpEF: The inflammatory paradigm Chair: Fausto Pinto Speaker: Adelino Leite-Moreira Panel: Manuel Campelo; Elisabete Martins |
| 10:00 | Industry Session Pfizer Cardiac amyloidosis in your HFpEF patient: where is it hiding from us? Chair: Elisabete Martins Speaker: Edward Philbin |
| 10:30 | HFpEF: therapies with potential disease modifying effect (MRA, S/V, ISGLT2-i) Chair: Jorge Ferreira Speaker: Ricardo Fontes-Carvalho Panel: Brenda Moura; Roberto Pinto |
| 11:00 | EMPEROR-Preserved trial: Bridging the Gap in HFpEF therapy Chair: Elisabete Martins Speaker: Pedro Morais Sarmento Panel: Cristina Gavina; Ana Oliveira Soares |
| 11:30 | The DYNAMIC study – Riociguat in HFpEF with pulmonary hypertension Chair: Manuel Vaz da Silva Speaker: Rui Plácido Panel: Bárbara Cardoso; Carlos Aguiar |
| 12:00 | Comorbidities in HFpEF: Focus on obesity and diabetes Chair: Miguel Mendes Speaker: João Agostinho Panel: Inês Araújo; Patrícia Rodrigues |
| 12:30 | Atrial fibrillation ablation in heart failure: indications and barriers Chair: João Primo Speaker: Diogo Cavaco Panel: João de Sousa; Pedro Cunha |
| 13:00 | Advances in HFrEF Pharmacotherapy – SGLT2i for all patient profiles? Speaker: José Ramón Juanatey |
- Tarde | 14:00 – 20:00
Afternoon – Heart Failure with preserved Ejection Fraction
| 14:00 | Sudden cardiac death risk in heart failure: Beyond left ventricular ejection fraction Chair: Luís Rocha Lopes Speaker: Alexandra Sousa Panel: Ana G. Almeida; Mariana Vasconcelos |
| 14:30 | Sudden cardiac death prevention in heart failure: The role of medical therapy Chair: Ana Teresa Timóteo Speaker: Nuno Cortez-Dias Panel: Luís Adão; Jorge Ferreira |
| 15:00 | Sudden cardiac death prevention in heart failure: Do recent pharmacological advances impact on ICD implantation indications? Chair: Pedro Adragão Speaker: Sérgio Barra Panel: Rui Baptista; Mónica Pedro |
| 15:30 | Novel devices in heart failure – Baroreflex activation therapy, interatrial shunts, and phrenic nerve stimulation Chair: Gonçalo Proença Speaker: Luís Oliveira Panel: Roberto Pinto; Alexandra Sousa |
| 16:00 | Advanced heart failure: Diagnosis and management Chair: José Fragata Speaker: Fátima Franco Panel: Doroteia Silva; Teresa Pinho |
| 16:30 | Industry Session Bayer Vericiguat: a new pharmacological option to reduce the burden of HFrEF Chair: Brenda Moura Speaker: Dulce Brito Panel: Brenda Moura; Dulce Brito |
| 17:00 | Advanced heart failure: Organization of care Chair: Aurora Andrade Speaker: Sandra Amorim Panel: António Ventosa; Paulo Maia Araújo |
| 17:30 | Industry Session Viforpharma Diagnosis and Readmission Prevention: Meet the New ESC 2021 Heart Failure Recommendations on Iron Deficiency Screening and Treatment Speakers: Dulce Brito; Rui Baptista |
| 18:00 | Addressing secondary mitral regurgitation in heart failure Chair: Manuel Antunes Speaker: António Fiarresga Panel: Rui André Rodrigues; Carla de Sousa |
| 18:30 | Tricuspid valve regurgitation intervention in heart failure Chair: Hélder Pereira Speaker: Bruno Mélica Panel: Ana G. Almeida; Mário Jorge Amorim |
| 19:00 | Long-term mechanical circulatory support and heart transplantation Chair: Paulo Pinho Speaker: José Pedro Neves Panel: Carolina Lourenço; Sandra Amorim |
| 19:30 | Transitioning to end of life care Chair: Hugo Madeira Speaker: Teresa Tavares Panel: Marta Nogueira; Paulo Santos |
| 20:00 | Meeting Closure Chairpersons: José Silva-Cardoso; Elisabete Martins |
MAIS INFORMAÇÕES
Este ano mantém-se ainda o formato virtual e o foco central será a divulgação em primeira mão dos desenvolvimentos científicos mais recentes nesta área apresentados no Congresso Europeu de Cardiologia, entre os quais se salientam as novas Recomendações da Sociedade Europeia de Cardiologia para a Insuficiência Cardíaca.
A reunião tem a coordenação científica de José Silva Cardoso e Elisabete Martins e a coordenação executiva de Emilia Moreira. Como é tradição, contará com um corpo docente que envolverá os peritos nacionais mais salientes nesta área e convidados internacionais de relevo.
Gostaríamos de poder contar com o imprescindível apoio da Indústria Farmacêutica, a qual consideramos um parceiro fundamental para o sucesso deste evento.
Caso desejem privilegiar-nos com a vossa colaboração, a empresa GetDone, responsável pela logística, clarificará convosco a forma como gostariam de estar presentes na reunião e a natureza do vosso apoio.
@ Advances in Heart Failure 2024. Todos os direitos reservados.
